Editor’s Note June 5, 2012
This week, we respond to a recent Wall Street Journal article documenting immunotherapy as a new treatment for Cancer. We tell you what companies they […]
Uncategorized
Biovest Seeking Marketing Approval in the EU for BiovaxID® Personalized Lymphoma Cancer Vaccine
Biovest has developed a patient-specific, cancer vaccine, BiovaxID®, with three clinical trials completed.
Editor’s Note May 22, 2012
This week, OneMedRadio brings you two management interviews. Iconic Data, CEO David LaBorde discusses their lead product SwiftPayMD and why it is changing the face […]
Alzheimer’s Drug Market Is Forecast to Experience Double-Digit Growth
Valued at almost $6bn in the seven major markets in 2011 (US, Japan, France, Germany, Italy, Spain, and the UK), the Alzheimer’s disease drug market is forecast to experience double-digit growth to 2020.
MPR Associates Talk Successful Product Development
Below Christian Haller and Marcus Hadley of MPR Associates discuss successful product development processes. They note three main characteristics: 1) clear direction and leadership from […]
“Rockstar of Science”, Eric Topol M.D. Talks The Creative Destruction of Medicine
Author of “The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Healthcare”, Dr. Eric Topol sits down with OneMedRadio to discuss the ideas and inspiration behind the book.
Editor’s Note May 22, 2012
This week, OneMedPlace brings you the final interview in our MPR series. A thorough discussion with design engineers Leon Marucchi and Katie McHugh give us […]
Project Management and Execution in Medical Device Development
As part of a OneMedRadio series, MPR Associates takes us through the process of medical device development.
CIN Special Report: Part II, Treatments Ready to Eradicate Pre-Cervical Cancer
Part II of the report identifies several disruptive technologies that may overcome the challenges of mainstream treatments.
Editor’s Note May 1, 2012
This week, OneMedPlace brings you a special report on CIN. In response to some recent successes by several companies operating in the cervical cancer space, […]